Follow the SRN stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on AU AU, under the authority of ASX. Operating in the Chemicals & Materials sector, SRN has published 2 reports. Market capitalisation: €3.4m. The latest transaction was filed on 13 May 2026 (Purchase). Among the most active insiders: Vladimir Nikolaenko. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations